Business
Conditional Subscription with Angelfish Investm...
Conditional Subscription with Angelfish Investm....
About this update from Serval Resources Plc
[{"type":"text","content":"\n \n THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (\"MAR\"). ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE (\"RIS\"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n DiscovOre plc\n \n \n AQSE: ORE\n \n (“DiscovOre plc” or the “Company”)\n \n Conditional Subscription Agreement with Angelfish Investments plc\n \n \n Particulars of the RIS Announcement:\n \n \n \n Angelfish Investments plc: Overview\n \n \n Conditional Participation in oversubscribed, £2,000,500 fund raise\n \n \n Related Party Disclosure\n \n \n Director Statement\n \n \n \n 1.\n Angelfish Investments plc: Overview\n \n Angelfish Investments plc (“Angelfish”) is a listed investment issuer on the AQSE Growth Market (AQSE: ANGP). The company’s current investment strategy is to invest in start-up ventures, primarily in the technology and health sectors.\n In April 2021, Burns Singh Tennent-Bhohi [a Director of DiscovOre plc] and\n Simon Grant-Rennick led a restructure and recapitalisation of Angelfish Investments plc, in conjunction with joining the Board of Directors.\n Angelfish has today announced and posted a circular to convene a General Meeting to seek shareholder approval of proposals that, if successful, would see Angelfish become a premier Biotech and MedTech investment issuer in the U.K.;\n \n Proposals to shareholders include:\n \n Subscription for New Ordinary Shares by way of an oversubscribed brokered placing conducted by Peterhouse Capital Limited\n Share Consolidation and Subdivision\n \n Co-Investment Rights to Excalibur Healthcare Services Limited\n \n \n Appointment of Directors\n \n Adoption of New Investment Policy\n Change of Name to Igraine plc and proposed new ticker, AQSE: KING\n \n \n Co-Investment Rights to Excalibur Healthcare Services:\n Excalibur Healthcare Services (“Excalibur”) was founded and is owned by Sir Professor Christopher Evans OBE, a renowned biotech entrepreneur.\n Conditional on shareholder approval, Excalibur has granted Angelfish the rights to co-invest in all healthcare and life-science investment opportunities sourced or invested into by Excalibur.\n \n Appointment of Directors including:\n \n Sir Professor Chri...